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Abstract
Parechoviruses (PeVs) are highly prevalent viruses worldwide. Over the last decades, several studies have been published 
on PeV epidemiology in Europe, Asia and North America, while information on other continents is lacking. The aim of this 
study was to describe PeV circulation in a cohort of children in Malawi, Africa. A total of 749 stool samples obtained from 
Malawian children aged 6 to 60 months were tested for the presence of PeV by real-time PCR. We performed typing by 
phylogenetic and Basic Local Alignment Search Tool (BLAST) analysis. PeV was found in 57% of stool samples. Age was 
significantly associated with PeV positivity (p = 0.01). Typing by phylogenetic analysis resulted in 15 different types, while 
BLAST typing resulted in 14 different types and several indeterminate strains. In total, six strains showed inconsistencies 
in typing between the two methods. One strain, P02-4058, remained untypable by all methods, but appeared to belong to 
the recently reclassified PeV-A19 genotype. PeV-A1, -A2 and -A3 were the most prevalent types (26.8%, 13.8% and 9.8%, 
respectively). Both the prevalence and genetic diversity found in our study were remarkably high. Our data provide an 
important contribution to the scarce data available on PeV epidemiology in Africa.
Abbreviations
PeV  Parechovirus
(q)PCR  (Quantitative) polymerase chain reaction
Ct-value  Threshold cycle value
Bp  Base pairs
UTR  Untranslated region
VP1  Virus protein 1
nt  Nucleotide
aa  Amino acid
BLAST  Basic Local Alignment Search Tool
Introduction
Members of the genus Parechovirus (PeV) within the fam-
ily Picornaviridae are small single-stranded RNA viruses. 
PeVs belonging to the species Parechovirus A, previously 
known as “Human parechovirus”, infect humans and can 
cause a variety of symptoms, including gastrointestinal and 
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respiratory symptoms. Currently, 19 types of PeV-A have 
been distinguished, named PeV-A1-19. PeV-A3 in particu-
lar is a known cause of severe neurological disease such 
as meningitis and encephalitis, mainly in young children 
[1, 2]. For assigning new clinical strains to a type, several 
rules and methods have been proposed: typing based on the 
VP1 sequence with a 75% nucleotide (nt) sequence identity 
threshold [3], typing based the VP1 sequence with a 77% 
nt sequence identity threshold and an 87% amino acid (aa) 
sequence identity threshold [4], and typing based on the 
VP3/VP1 junction region sequence with a 82% nt and 92% 
aa sequence identity threshold [5]. Over the last decades, 
PeVs have been shown to be highly prevalent around the 
world. While in Europe and the USA, studies usually find a 
PeV prevalence (i.e. prevalence of viral RNA or infectious 
virus in clinical or surveillance samples) between 1 and 7% 
[6–11], PeV prevalence in Asia has been reported to be as 
high as 25% [12–15]. The most prevalent types in all of 
these geographical regions are PeV-A1 and -A3 [2, 7–10, 
12–15]. Data on PeV circulation in Africa are scarce; only 
three studies have been conducted – in Kenya, Côte d’Ivoire 
and Ghana – finding very divergent prevalences (2%, 5.2% 
and 24% respectively) [16–18]. The aim of this study was 
to contribute to the little knowledge available on PeV cir-
culation in Africa. For this, we tested samples collected in 
a cross-sectional study in Malawi for the presence of PeV.
Materials and methods
Patients and samples
A total of 749 fecal samples collected from Malawian chil-
dren included in the SevAna study on severe anemia were 
included in this study [19]. The samples were collected 
between 2002 and 2004 from children included in one of 
three inclusion groups: children presenting with severe ane-
mia (hemoglobin <5g/dl), hospital controls without severe 
anemia, and community controls without severe anemia. 
All of the included children were between 6 and 60 months 
of age. A questionnaire on demographic and clinical infor-
mation (i.e. specific respiratory, gastrointestinal, central 
nervous system, and other symptoms) was completed for 
each participant, and clinical findings were reported. The 
fecal samples were stored at -80°C prior to analysis.
Nucleic acid extraction and PeV detection
Nucleic acids were extracted from all samples by the 
method of Boom et al. [20]. An RT-PCR was performed as 
described previously [21] using primers PeV F31 and PeV 
K30 (Table 1). Samples with a Ct value ≤40 were consid-
ered to be PeV positive. Samples with a Ct value ≤30 were 
included for typing.
PeV typing and phylogenetic analysis
The complete VP1 region was sequenced for typing (Cremer 
et al., manuscript submitted). In short, a nested PCR was 
conducted using primers PeV R1, F1, R2 and F2 (Table 1). 
The PCR products were analyzed by agarose gel electro-
phoresis. Positive samples with a PCR fragment size of 
1000-1100 base pairs (bp) were included for sequencing. 
The sequencing reaction was performed using a Big Dye 
Terminator Kit and primers PeV F2 and PeV R2 (Table 1). 
Sample sequences were assembled in CodonCode Aligner 
(version 6.0.2) and aligned with Mafft version 7 software 
(https ://mafft .cbrc.jp/align ment/softw are/) using the L-INS-
i method. Maximum-likelihood (ML) phylogenetic trees 
including all sample strains and reference strains from the 
GenBank database were constructed for the VP1 sequence 
(nt positions 2336 to 3037 of the reference genome sequence 
of the Harris PeV-A1 strain [accession no. L02791]) and 
the VP3/VP1 junction region (nt positions 2182 to 2437) 
using RaxML version 8.2.12 [22] with the generalized time-
reversible (GTR) nucleotide substitution model, the gamma 
model of rate heterogeneity, and 1000 bootstrap replicates. 
A Neighbor-joining (NJ) tree including the same strains was 
constructed for the VP1 sequence alignment using Mega7 
(p-distance, 1000 bootstrap replicates) [23]. In addition, the 
nucleotide sequences were compared to reference strains in 
the GenBank database using Nucleotide Basic Local Align-
ment Search Tool (BLASTn) (NCBI, https ://blast .ncbi.
nlm.nih.gov/ accessed 1st February 2018) with standard 
Table 1  Primers and probes 
used for RT-PCR (primers 
Parecho F31, Parecho K30 and 
probe WT-MGB), nested PCR 
(primers PeV F1, PeV R1, PeV 
F2 and PeV R2) and sequencing 
(primers PeV F2 and PeV R2)
Primer or probe Sequence (5’-3’) Polarity Gene
Parecho F31 CTG GGG CCA AAA GCCA Forward 5’UTR 
Parecho K30 GGT ACC TTC TGG GCA TCC TTC Reverse 5’UTR 
PeV F1 TNMGNATGGGNTTY TTY CCNAAY Forward VP1
PeV R1 ART ART CNARY TCR CAY TCY TC Reverse VP1
PeV F2 GAG TTG GAC AAT GCC ATC TAYACNATNTGYG Forward VP1
PeV R2 GTT CCT GTT AGA GCT GTC TTRAANATR TCR TC Reverse VP1
WT-MGB (probe) AAA CAC TAG TTG TAW GGC CC 5’UTR 
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settings for megablast (i.e., word size 28; match/mismatch 
scores 1, -2; linear gap costs). For strains with BLASTn 
genotyping results that were either unclear or conflicted 
with results obtained by either phylogenetic method, we 
searched for the translated protein sequence using tBLASTn 
(word size, 6; substitution matrix, BLOSUM62; gap exist-
ence cost, 11; gap extension cost, 1). No sequences of the 
recently reclassified PeV-A19 were available in GenBank. 
As a result, for all methods, typing could only be performed 
for PeV-A1 through -A18. The newly obtained nucleotide 
sequences were deposited in the DDBJ/EMBL/GenBank 
nucleotide sequence databases with accession numbers 
MH339618-MH339740.
Statistical analysis
Demographics were calculated in frequencies and percent-
ages. For age, the median and interquartile range (IQR) (Q1-
Q3) were calculated. The association between gender and 
PeV positivity, as well as between inclusion group and PeV 
positivity was determined by a chi-square test. The associa-
tion between PeV positivity and age was calculated using 
the Mann-Whitney U test. Chi-square tests were performed 
for the association between PeV positivity and potential PeV 
symptoms (gastrointestinal, respiratory and central nervous 
system (CNS) symptoms and fever). All statistical analyses 
were performed using IBM SPSS Statistics 24.
Results
PeV prevalence in Malawian children
The baseline characteristics gender and age as well as PeV 
prevalence were comparable among the inclusion groups 
(Table 2). In total, 427 (57.0%) of the 749 samples tested 
positive for PeV (Table 2, Fig. 1). As data on age were lack-
ing for nine participants, the remaining 740 participants 
were included for analysis on the association between age 
and PeV-positivity (α = 0.05). PeV positivity was signifi-
cantly associated with age. PeV positive participants had a 
mean age of 1.8 years, and PeV-negative participants had a 
mean age of 2.0 years (p = 0.01). The proportion of PeV-
positive participants was highest in children under 1 year of 
age (64.0%) and declined with increasing age to 47.2% in 
Table 2  Baseline characteristics of the 749 participants. The partici-
pants were included in the SevAna study on severe anemia between 
2002 and 2004, in one of three inclusion groups: children presenting 
with severe anemia (hemoglobin <5 g/dl), hospital controls without 
severe anemia, and community controls without severe anemia. All of 
the children were between 6 and 60 months of age
*Information on inclusion group was lacking for 12 of the participants
Severe anemia (n = 227, 
30.3%)
Hospital control (n = 261, 
34.8%)
Community control (n = 249, 
33.2%)
Total (n = 749)*
Male gender (no., %) 107 (47.1) 133 (51.4) 120 (48.2) 371 (49.7)
Age (median, IQR) 1.30 (0.85-2.16) 1.76 (1.06-2.40) 2.00 (1.20-3.01) 1.64 (1.02 – 2.60)
PeV positive (no.,%) 128 (56.4) 142 (54.4) 148 (59.4) 427 (57.0)
Fig. 1  Flowchart showing all included samples















Fig. 2  Percentage of participants (n = 740; data on age were lacking 
for nine of the 749 participants) with a PeV-positive stool sample by 
age
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Fig. 3  Phylogenetic trees including our study strains and selected 
reference strains from the GenBank database. Phylogenetic analy-
sis was performed on the VP1 sequence alignment (A) and VP3/
VP1 junction region sequence alignment (B) using the maximum-
likelihood (ML) method with the generalized time-reversible (GTR) 
nucleotide substitution model (1000 bootstrap replicates), and on the 
VP1 sequence alignment using the neighbor-joining (NJ) method 
(p-distance, 1000 bootstrap replicates) (C). For all study strains (P0X-
XXXX, circles shaded according to their predicted genotype accord-
ing to phylogenetic analyses of VP1), the year of collection is indi-
cated (P02, 2002; P03, 2003; P04, 2004). For all reference strains 
(open circles), the country and year of collection and the accession 
number are given. Strains with inconsistent typing results between 
the different phylogeny methods and/or BLAST are marked in bold. 
The untypable strain P02-4058  is labeled  as PeV-A19 in this fig-
ure, according to the  typing of this strain by the Picornavirus Study 
Group. Bootstrap values ≥70% are shown for the branches (ML-trees) 
or nodes (NJ-trees)
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children aged 4 years (Fig. 2). PeV positivity was not asso-
ciated with gender (p = 0.6), inclusion group (p = 0.5) or 
potential PeV-related symptoms (gastrointestinal [p = 0.6], 
respiratory [p = 0.9] or CNS symptoms [p = 0.6] or fever 
[p = 0.8]).  
Genotype distribution
Out of 427 samples tested, 190 (44.5%) had a Ct value 
≤30 and were included for additional genotyping. Good-
quality sequences were obtained from 123 of 190 samples, 
which were typed (64.7%) (Fig.  1) using the following 
methods: ML phylogeny of the VP1, ML phylogeny of the 
VP3/VP1 junction region, NJ phylogeny of the VP1, or 
comparison to reference strains in GenBank using BLAST. 
NJ and ML phylogeny of the study strain VP1 sequences 
together with PeV reference strains extracted from Gen-
Bank showed that PeV-A1 was the most prevalent geno-
type (33/123, 26.8%), followed by PeV-A2 (17/123, 13.8%), 
PeV-A3 (12/123, 9.8%), and PeV-A4 (11/123, 9.0%). Other 
genotypes found were PeV-A5, PeV-A8 (both 10/123, 8.1%), 
PeV-A16 (7/123, 6.0%), PeV-A10, -A17, -A12 (4/123, 
3.3%), PeV-A6, -A14 (3/123, 2.4%), PeV-A9 (2/123, 1.6%), 
PeV-A7 and -A11 (1/123, 0.8%) (Fig. 3, Table 3). Strain 
P02-4058 was distinct from all genotypes but was closest 
to PeV-A6, with a mean p-distance of 0.297. For PeV-A1, 
28 strains grouped within the PeV-A1a cluster, while five 
grouped within the PeV-A1b cluster (Fig. 3). 
Genotyping by ML phylogenetic analysis based on the 
VP1/VP3 junction region resulted in two inconsistencies 
compared to the analyses based on VP1: P02-4058 grouped 
closer to PeV-A18 (p-distance, 0.221) and -A15 (p-distance, 
0.218), and P04-4393 grouped within the PeV-A8 group 
(Fig. 3c, Table 3). Typing the VP1 nucleotide sequences 
using BLAST analysis (cutoff at 77% sequence identity) 
resulted in inconsistencies for 11 strains compared to the 
phylogenetic analyses based on VP1 (P02-4058; P03-1117, 
-1118, -4139, -4183, -4273, -4275, -4312; P04-1310, -1475, 
-1556). Typing the translated aa sequences by BLAST anay-
sis (cutoff at 87% sequence identity) resolved the inconsist-
encies for six strains. The five remaining strains for which 
typing was not resolved included four strains that had been 
typed as PeV-A17 by phylogenetic analyses based on VP1 
(P03-1118, P03-4312, P04-1310, P04-1556) and the untyped 
strain P02-4058. The PeV-A17 strains showed ≥77% nt and 
≥87% aa sequence identity to both PeV-A3 and PeV-A17 
strains by BLAST analysis, and therefore remained indeter-
minate. Strain P02-4058 showed less than 77% nt sequence 
identity and less than 87% aa sequence identity to any geno-
type and therefore remained indeterminate (Table 3 and S1).
Discussion
We found a remarkably high PeV prevalence (57%) within a 
cohort of Malawian children between 2002 and 2004. This 
prevalence is much higher than the PeV frequencies found 
in Asia, Europe and North America [6–10, 12–15, 24–31]. 
Recently, a PeV prevalence of 24% was found in a cohort 
of Ghanaian children [18], pointing towards a higher PeV 
prevalence in Africa than in other continents. The same 
seems to be the case for enteroviruses, for which the reported 
prevalence in this and other cohorts in Africa is higher than 
elsewhere in the world [32–35]. We speculate that poorer 
hygiene than in more developed countries is a possible expla-
nation for the high prevalence. Alternatively, other factors 
may have contributed to the high prevalence of PeV found in 
our study. Higher prevalence of PeVs was previously reported 
in the rainy season compared to the dry season in Ghana 
[18]. The fact that the vast majority of our samples were col-
lected during the rainy season, when malaria mainly occurs, 
might have contributed to the high prevalence. Furthermore, 
PeVs are known to circulate primarily in very young popu-
lations [1], and overall, studies that included children aged 
up to 5 years found higher frequencies of PeV than studies 
that included older children and/or adults [10, 14, 17, 18, 
24, 25, 30, 31]. The fact that our population consisted solely 
of children between 6 and 60 months of age, will therefore 
have contributed to the high PeV prevalence. As there was 
no association between PeV positivity and inclusion groups, 
we consider it unlikely that hospital-acquired infections or 
the presence of severe anemia biased the results.
Although PeV is known to cause cases of severe dis-
ease [36, 37], PeV infection is predominantly subclinical. 
Seroepidemiological studies have shown that the majority 
of children are positive for PeV neutralizing antibodies by 
the age of 5 years [38–41]. In line with this, we did not find 
a significant association between PeV infection and clini-
cal symptoms. PeV3 in particular is known to cause severe 
disease, such as meningitis, encephalitis and sepsis-like ill-
ness, mainly in children under three months of age [36, 37]. 
However, the 11 PeV3-positive participants in our study, 
all above the age of six months, did not show signs of CNS 
infection or sepsis.
We performed typing using different, frequently used 
methods: NJ phylogeny based on the VP1 sequence, ML 
phylogeny based on the VP1 sequence, ML phylogeny 
based on the VP3/VP1 junction region sequence, and typ-
ing by BLAST analysis. Typing using NJ and ML phylo-
genetic trees identified 15 different PeV genotypes in our 
study; all genotypes except PeV-A13, -A15, and -A18 were 
found. Typing using BLAST resulted in 14 different PeV 
genotypes – all genotypes except PeV-A13, -A15, -A17, and 
-A18– while five strains had ambiguous results and were 
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labeled indeterminate. Strain P02-4058 remained untypa-
ble by all methods. However, a similar strain had recently 
been submitted to the Picornavirus Study Group and was 
classified as PeV-A19 after minor reorganizations of the 
PeV-A classification (Roland Zell, personal communica-
tion, December 2018). Strain P02-4058 was therefore typed 
as PeV-A19. Strain P04-4393 was typed as PeV-A14 based 
on the VP1-sequence and as PeV-A8 based on the VP3/VP1 
junction sequence. Although recombination events in the 
structural parts of PeV genomes are rare, they do occur and 
could possibly explain the different typing results obtained 
by different methods [42]. Our data are in line with find-
ings in Ghana, where all genotypes were identified except 
PeV-A11, -A13, -A16 and -A19 [18]. We speculate that this 
may reflect regional differences, with a wider variety of PeV 
genotypes circulating in Africa than in Europe, North Amer-
ica and Asia, where types other than PeV-A1-6 are rarely 
seen [2, 7–10, 12–14]. Of the genotypes found in our study, 
PeV-A1, -A2 and -A3 were most prevalent. While PeV-A1 
is known to circulate extensively around the world, PeV-A2 
is a relatively rare genotype [9, 10, 14, 27, 29]. The high 
prevalence of this genotype in our study is therefore notable. 
While PeV-A3 is also highly prevalent worldwide [9, 10, 14, 
27, 29], our results are in contrast with studies conducted in 
Ghana and Côte d’Ivoire, where no PeV-A3 was reported 
[17, 18]. Since PeV-A3 circulates more widely in children 
under the age of 3 months [9, 26–28], we speculate that the 
proportion of PeV-A3-positive samples in this study would 
have been even higher if children under the age of 6 months 
had been included.
Different rules and methods to type PeV strains have been 
proposed in recent years, and currently, there is no consensus 
regarding which specific method to use. As a result, typ-
ing is performed using different regions and lengths of the 
viral genome [3–5] and by using different methods, such as 
BLAST, NJ phylogeny and ML phylogeny [13, 14, 17, 25, 
27, 30, 43]. We have shown that these methods can result in 
different typing results for the same viral strain, leading to 
inconsistent and possibly incorrect typing of PeV strains. We 
believe that consensus on a genotyping framework, prefer-
ably based on distinct clustering in a specialized phyloge-
netic analysis, is needed and would provide more accurate 
and consistent typing in further studies.
In conclusion, we found a high frequency of PeV circula-
tion in a population of Malawian children. We saw multiple 
inconsistencies in typing of strains when comparing BLAST 
and phylogenetic methods. However, with all methods, 
we found a wide variety of genotypes, with PeV-A1, -A2 
and -A3 being the most prevalent types. The presence of 
the higher-numbered genotypes (PeV-A7-12, -A14, -A16, 
-A17 and -A19) and the high prevalence of PeV-A2 are espe-
cially notable. Further studies and surveillance are needed to 
elucidate the impact of the high prevalence and diversity of 
PeV and its clinical relevance on this continent. Moreover, in 
the future, a consensus on a typing method may be required 
to avoid inconsistent typing.
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Table 3  Strains typed as genotype PeV-A1 through PeV-A18 by 
phylogenetic analysis of the VP1 sequence (maximum-likelihood 
[ML] and neighbor-joining [NJ] phylogeny gave identical results) 
by phylogeny of the VP3/VP1 junction region and by comparing the 
sequences to reference strains in the GenBank database using BLAST 
(NCBI, https ://blast .ncbi.nlm.nih.gov/, accessed February 1, 2018). 
Types that contained strains with inconsistent outcomes between the 
methods are marked in bold. The indeterminate strains include strain 
P02-4058, which  was later typed as PeV-A19  by the Picornavirus 
Study Group
Phylogeny VP1 Phylogeny VP3/
VP1
BLAST
Genotype No. of strains No. of strains No. of strains
PeV-A1 33 33 33
PeV-A2 17 17 17
PeV-A3 12 12 12
PeV-A4 11 11 11
PeV-A5 10 10 10
PeV-A6 3 3 3
PeV-A7 1 1 1
PeV-A8 10 11 10
PeV-A9 2 2 2
PeV-A10 4 4 4
PeV-A11 1 1 1
PeV-A12 4 4 4
PeV-A13 - - -
PeV-A14 3 2 3 
PeV-A15 - - -
PeV-A16 7 7 7
PeV-A17 4 4 -
PeV-A18 - - -
Indeterminate 1 1 5
Total 123 123 123
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